{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:51:15Z","timestamp":1783666275361,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["GPO-A-00-04-00019-00"],"award-info":[{"award-number":["GPO-A-00-04-00019-00"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P51OD011104-56"],"award-info":[{"award-number":["P51OD011104-56"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) strategies with proven in vivo efficacy rely on antiretroviral drugs, creating the potential for drug resistance and complicated treatment options in individuals who become infected. Moreover, on-demand products are currently missing from the PrEP development portfolio. Griffithsin (GRFT) is a non-antiretroviral HIV entry inhibitor derived from red algae with an excellent safety profile and potent activity in vitro. When combined with carrageenan (CG), GRFT has strong activity against herpes simplex virus-2 (HSV-2) and human papillomavirus (HPV) in vitro and in vivo. Here, we report that GRFT\/CG in a freeze-dried fast dissolving insert (FDI) formulation for on-demand use protects rhesus macaques from a high dose vaginal SHIV SF162P3 challenge 4\u2009h after FDI insertion. Furthermore, the GRFT\/CG FDI also protects mice vaginally against HSV-2 and HPV pseudovirus. As a safe, potent, broad-spectrum, on-demand non-antiretroviral product, the GRFT\/CG FDI warrants clinical development.<\/jats:p>","DOI":"10.1038\/s41467-018-06349-0","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T11:32:41Z","timestamp":1537270361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo"],"prefix":"10.1038","volume":"9","author":[{"given":"Nina","family":"Derby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meropi","family":"Aravantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Kizima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Barnable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixa","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manshun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Wesenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Ugaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Levendosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mizenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Kleinbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Lifson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Melissa","family":"Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Heneine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-4856","authenticated-orcid":false,"given":"Barry R","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Robbiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Grasperge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agegnehu","family":"Gettie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Teleshova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Fern\u00e1ndez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Zydowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"issue":"6","key":"6349_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s13346-017-0385-4","volume":"7","author":"Sravan Kumar Patel","year":"2017","unstructured":"Patel, S. K. & Rohan, L. C. On-demand microbicide products: design matters. Drug Deliv. Transl. Res. 7, 775\u2013795 (2017).","journal-title":"Drug Delivery and Translational Research"},{"key":"6349_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/157016212799304625","volume":"10","author":"JW Romano","year":"2012","unstructured":"Romano, J. W., Robbiani, M., Doncel, G. F. & Moench, T. Non-specific microbicide product development: then and now. Curr. Hiv. Res. 10, 9\u201318 (2012).","journal-title":"Curr. Hiv. Res."},{"key":"6349_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/088922204322749459","volume":"20","author":"CC Tsai","year":"2004","unstructured":"Tsai, C. C. et al. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res. Hum. Retrovir. 20, 11\u201318 (2004).","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"6349_CR4","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/mi.2011.30","volume":"4","author":"LA Lagenaur","year":"2011","unstructured":"Lagenaur, L. A. et al. Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol. 4, 648\u2013657 (2011).","journal-title":"Mucosal Immunol."},{"key":"6349_CR5","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1016\/j.biocel.2008.05.023","volume":"40","author":"D Huskens","year":"2008","unstructured":"Huskens, D., Vermeire, K., Vandemeulebroucke, E., Balzarini, J. & Schols, D. Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent. Int. J. Biochem. Cell. Biol. 40, 2802\u20132814 (2008).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"6349_CR6","doi-asserted-by":"publisher","first-page":"e22635","DOI":"10.1371\/journal.pone.0022635","volume":"6","author":"JC Kouokam","year":"2011","unstructured":"Kouokam, J. C. et al. Investigation of griffithsin\u2019s interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate. PLoS One 6, e22635 (2011).","journal-title":"PLoS One"},{"key":"6349_CR7","doi-asserted-by":"publisher","first-page":"6257","DOI":"10.1128\/JVI.00012-13","volume":"87","author":"B Nixon","year":"2013","unstructured":"Nixon, B. et al. Griffithsin protects mice from genital herpes by preventing cell-to-cell spread. J. Virol. 87, 6257\u20136269 (2013).","journal-title":"J. Virol."},{"key":"6349_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.virol.2011.12.001","volume":"423","author":"KB Alexandre","year":"2012","unstructured":"Alexandre, K. B. et al. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells. Virology 423, 175\u2013186 (2012).","journal-title":"Virology"},{"key":"6349_CR9","doi-asserted-by":"publisher","first-page":"9039","DOI":"10.1128\/JVI.02675-10","volume":"85","author":"KB Alexandre","year":"2011","unstructured":"Alexandre, K. B. et al. Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site. J. Virol. 85, 9039\u20139050 (2011).","journal-title":"J. Virol."},{"key":"6349_CR10","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1074\/jbc.M411122200","volume":"280","author":"T Mori","year":"2005","unstructured":"Mori, T. et al. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J. Biol. Chem. 280, 9345\u20139353 (2005).","journal-title":"J. Biol. Chem."},{"key":"6349_CR11","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1073\/pnas.0901506106","volume":"106","author":"BR O\u2019Keefe","year":"2009","unstructured":"O\u2019Keefe, B. R. et al. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc. Natl Acad. Sci. USA 106, 6099\u20136104 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6349_CR12","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1128\/AAC.01816-15","volume":"59","author":"K Levendosky","year":"2015","unstructured":"Levendosky, K. et al. Griffithsin and carrageenan combination to target Herpes Simplex Virus 2 and Human Papillomavirus. Antimicrob. Agents Chemother. 59, 7290\u20137298 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6349_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1473-3099(17)30405-X","volume":"17","author":"KJ Looker","year":"2017","unstructured":"Looker, K. J. et al. Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis. Lancet Infect. Dis. 17, 1303\u20131316 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"6349_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.contraception.2015.09.002","volume":"93","author":"E Schelar","year":"2016","unstructured":"Schelar, E. et al. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products. Contraception 93, 32\u201343 (2016).","journal-title":"Contraception"},{"key":"6349_CR15","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1097\/QAD.0b013e328358d908","volume":"26","author":"CF Houlihan","year":"2012","unstructured":"Houlihan, C. F. et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 26, 2211\u20132222 (2012).","journal-title":"AIDS"},{"key":"6349_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S1473-3099(08)70181-6","volume":"8","author":"P Van de Perre","year":"2008","unstructured":"Van de Perre, P. et al. Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect. Dis. 8, 490\u2013497 (2008).","journal-title":"Lancet Infect. Dis."},{"key":"6349_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1158\/1055-9965.EPI-16-0700","volume":"26","author":"HK Whitham","year":"2017","unstructured":"Whitham, H. K. et al. A comparison of the natural history of HPV infection and cervical abnormalities among HIV-positive and HIV-negative women in Senegal, Africa. Cancer Epidemiol. Biomark. Prev. 26, 886\u2013894 (2017).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"6349_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tim.2015.02.006","volume":"23","author":"JA Fernandez Romero","year":"2015","unstructured":"Fernandez Romero, J. A. et al. Multipurpose prevention technologies: the future of HIV and STI prevention. Trends Microbiol. 23, 429\u2013436 (2015).","journal-title":"Trends Microbiol."},{"key":"6349_CR19","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1371\/journal.ppat.0020069","volume":"2","author":"CB Buck","year":"2006","unstructured":"Buck, C. B. et al. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS. Pathog. 2, e69 (2006).","journal-title":"PLoS. Pathog."},{"key":"6349_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.antiviral.2014.05.018","volume":"108","author":"Aixa Rodr\u00edguez","year":"2014","unstructured":"Rodriguez, A., et al. In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition. Antivir. Res. 108, 88\u201393 (2014).","journal-title":"Antiviral Research"},{"key":"6349_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ygyno.2016.09.003","volume":"143","author":"AP Novetsky","year":"2016","unstructured":"Novetsky, A. P. et al. In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel. Gynecol. Oncol. 143, 313\u2013318 (2016).","journal-title":"Gynecol. Oncol."},{"key":"6349_CR22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nm1598","volume":"13","author":"JN Roberts","year":"2007","unstructured":"Roberts, J. N. et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 13, 857\u2013861 (2007).","journal-title":"Nat. Med."},{"key":"6349_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/jnci\/djr061","volume":"103","author":"JN Roberts","year":"2011","unstructured":"Roberts, J. N., Kines, R. C., Katki, H. A., Lowy, D. R. & Schiller, J. T. Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model. J. Natl Cancer Inst. 103, 737\u2013743 (2011).","journal-title":"J. Natl Cancer Inst."},{"key":"6349_CR24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1089\/aid.2010.0252","volume":"27","author":"O Begay","year":"2011","unstructured":"Begay, O. et al. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res. Hum. Retrovir. 27, 1019\u20131024 (2011).","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"6349_CR25","first-page":"S1198","volume":"X","author":"S Magnan","year":"2018","unstructured":"Magnan, S. et al. Efficacy of a carrageenan gel against transmission of cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial. Clin. Microbiol. Infect. X, S1198\u2013S1743 (2018).","journal-title":"Clin. Microbiol. Infect."},{"issue":"12","key":"6349_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/v8120331","volume":"8","author":"Christopher Barton","year":"2016","unstructured":"Barton, C., Kouokam, J. C., Hurst, H. & Palmer, K. E. Pharmacokinetics of the antiviral lectin Griffithsin administered by different routes indicates multiple potential uses. Viruses 8, 331 (2016).","journal-title":"Viruses"},{"key":"6349_CR27","doi-asserted-by":"crossref","unstructured":"Lal, M., et al. Development of a vaginal fast-dissolving insert combining griffithsin and carrageenan for potential use against sexually transmitted infections. J. Pharm. Sci. (2018).","DOI":"10.1016\/j.xphs.2018.06.002"},{"key":"6349_CR28","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1128\/AAC.05810-11","volume":"56","author":"RK Malcolm","year":"2012","unstructured":"Malcolm, R. K. et al. Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques. Antimicrob. Agents Chemother. 56, 2251\u20132258 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6349_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/jmp.12188","volume":"44","author":"K Butler","year":"2015","unstructured":"Butler, K. et al. Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques. J. Med. Primatol. 44, 286\u2013295 (2015).","journal-title":"J. Med. Primatol."},{"key":"6349_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1128\/AAC.05461-11","volume":"56","author":"JA Fernandez-Romero","year":"2012","unstructured":"Fernandez-Romero, J. A. et al. Zinc acetate\/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. Antimicrob. Agents Chemother. 56, 358\u2013368 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6349_CR31","doi-asserted-by":"publisher","first-page":"e94547","DOI":"10.1371\/journal.pone.0094547","volume":"9","author":"L Kizima","year":"2014","unstructured":"Kizima, L. et al. A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV. PLoS One 9, e94547 (2014).","journal-title":"PLoS One"},{"key":"6349_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo, J. M. et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N. Engl. J. Med. 372, 509\u2013518 (2015).","journal-title":"N. Engl. J. Med."},{"key":"6349_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme, L. et al. Preexposure prophylaxis for HIV infection among African women. N. Engl. J. Med. 367, 411\u2013422 (2012).","journal-title":"N. Engl. J. Med."},{"key":"6349_CR34","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten, J. M. et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N. Engl. J. Med. 375, 2121\u20132132 (2016).","journal-title":"N. Engl. J. Med."},{"key":"6349_CR35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00002030-200103300-00012","volume":"15","author":"H Chakraborty","year":"2001","unstructured":"Chakraborty, H. et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 15, 621\u2013627 (2001).","journal-title":"AIDS"},{"key":"6349_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/OLQ.0b013e318141fe9b","volume":"35","author":"SC Kalichman","year":"2008","unstructured":"Kalichman, S. C., Di Berto, G. & Eaton, L. Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex. Transm. Dis. 35, 55\u201360 (2008).","journal-title":"Sex. Transm. Dis."},{"key":"6349_CR37","doi-asserted-by":"publisher","first-page":"F51","DOI":"10.1097\/00002030-199612000-00001","volume":"10","author":"G Liuzzi","year":"1996","unstructured":"Liuzzi, G. et al. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10, F51\u2013F56 (1996).","journal-title":"AIDS"},{"key":"6349_CR38","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1097\/QAD.0b013e3281532c82","volume":"21","author":"CD Pilcher","year":"2007","unstructured":"Pilcher, C. D. et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 21, 1723\u20131730 (2007).","journal-title":"AIDS"},{"key":"6349_CR39","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nm1096-1084","volume":"2","author":"PA Marx","year":"1996","unstructured":"Marx, P. A. et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 2, 1084\u20131089 (1996).","journal-title":"Nat. Med."},{"key":"6349_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/jmp.12299","volume":"46","author":"P Srinivasan","year":"2017","unstructured":"Srinivasan, P. et al. Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings. J. Med. Primatol. 46, 129\u2013136 (2017).","journal-title":"J. Med. Primatol."},{"key":"6349_CR41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1128\/JCM.00991-10","volume":"49","author":"C Mitchell","year":"2011","unstructured":"Mitchell, C. et al. Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women. J. Clin. Microbiol. 49, 735\u2013736 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"6349_CR42","doi-asserted-by":"publisher","first-page":"e0158687","DOI":"10.1371\/journal.pone.0158687","volume":"11","author":"BJ Moncla","year":"2016","unstructured":"Moncla, B. J., Chappell, C. A., Debo, B. M. & Meyn, L. A. The effects of hormones and vaginal microflora on the glycome of the female genital tract: cervical-vaginal fluid. PLoS One 11, e0158687 (2016).","journal-title":"PLoS One"},{"key":"6349_CR43","doi-asserted-by":"publisher","first-page":"e0127091","DOI":"10.1371\/journal.pone.0127091","volume":"10","author":"BJ Moncla","year":"2015","unstructured":"Moncla, B. J. et al. Impact of bacterial vaginosis, as assessed by nugent criteria and hormonal status on glycosidases and lectin binding in cervicovaginal lavage samples. PLoS. One. 10, e0127091 (2015).","journal-title":"PLoS. One."},{"key":"6349_CR44","unstructured":"Davis, D., Verschoor, E. J. & Fagrouch, Z. Envelope evolution of SHIVsf162p3 in rhesus macaques. in NCBI GenPept (2011)."},{"key":"6349_CR45","doi-asserted-by":"publisher","first-page":"e0130621","DOI":"10.1371\/journal.pone.0130621","volume":"10","author":"L Mathys","year":"2015","unstructured":"Mathys, L. & Balzarini, J. Several N-Glycans on the HIV envelope glycoprotein gp120 preferentially locate near disulphide bridges and are required for efficient infectivity and virus transmission. PLoS One 10, e0130621 (2015).","journal-title":"PLoS One"},{"key":"6349_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.virol.2013.07.019","volume":"446","author":"KB Alexandre","year":"2013","unstructured":"Alexandre, K. B. et al. Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN. Virology 446, 66\u201376 (2013).","journal-title":"Virology"},{"key":"6349_CR47","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1097\/QAI.0000000000001167","volume":"74","author":"G Calenda","year":"2017","unstructured":"Calenda, G. et al. MZC gel inhibits SHIV-RT and HSV-2 in macaque vaginal mucosa and SHIV-RT in rectal mucosa. J. Acquir. Immune Defic. Syndr. 74, e67\u2013e74 (2017).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"6349_CR48","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1089\/aid.2014.0207","volume":"30","author":"J Kenney","year":"2014","unstructured":"Kenney, J. et al. Short communication: a repeated simian human immunodeficiency virus reverse transcriptase\/herpes simplex virus type 2 cochallenge macaque model for the evaluation of microbicides. AIDS Res. Hum. Retrovir. 30, 1117\u20131124 (2014).","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"6","key":"6349_CR49","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s13346-017-0389-0","volume":"7","author":"Nina Derby","year":"2017","unstructured":"Derby, N., et al. An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques. Drug Deliv. Transl. Res. 7, 840\u2013858 (2017).","journal-title":"Drug Delivery and Translational Research"},{"key":"6349_CR50","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/nature07831","volume":"458","author":"Q Li","year":"2009","unstructured":"Li, Q. et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458, 1034\u20131038 (2009).","journal-title":"Nature"},{"key":"6349_CR51","unstructured":"Animal Welfare Act and Regulation. in Animals and animal products (ed. Code of Federal Regulations) Ch. 1, SubCh. A (U.S. Department of Agriculture, Beltsville, 2001)."},{"key":"6349_CR52","unstructured":"National Research Council. Guide for the Care and Use of Laboratory Animals: Eighth Edition, (The National Academies Press, 2011)."},{"key":"6349_CR53","doi-asserted-by":"publisher","first-page":"e1005720","DOI":"10.1371\/journal.ppat.1005720","volume":"12","author":"G Arrode-Bruses","year":"2016","unstructured":"Arrode-Bruses, G. et al. A small molecule, which competes with MAdCAM-1, activates integrin alpha4beta7 and fails to prevent mucosal transmission of SHIV-SF162P3. PLoS Pathog. 12, e1005720 (2016).","journal-title":"PLoS Pathog."},{"key":"6349_CR54","doi-asserted-by":"publisher","first-page":"e0161730","DOI":"10.1371\/journal.pone.0161730","volume":"11","author":"M Aravantinou","year":"2016","unstructured":"Aravantinou, M. et al. PolyICLC exerts pro- and anti-hiv effects on the DC-T cell Milieu in vitro and in vivo. PLoS One 11, e0161730 (2016).","journal-title":"PLoS One"},{"key":"6349_CR55","doi-asserted-by":"publisher","first-page":"150ra123","DOI":"10.1126\/scitranslmed.3003936","volume":"4","author":"R Singer","year":"2012","unstructured":"Singer, R. et al. An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques. Sci. Transl. Med. 4, 150ra123 (2012).","journal-title":"Sci. Transl. Med."},{"key":"6349_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature12519","volume":"502","author":"SG Hansen","year":"2013","unstructured":"Hansen, S. G. et al. Immune clearance of highly pathogenic SIV infection. Nature 502, 100\u2013104 (2013).","journal-title":"Nature"},{"key":"6349_CR57","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1128\/AAC.00073-15","volume":"59","author":"P Barnable","year":"2015","unstructured":"Barnable, P. et al. MIV-150\/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model. Antimicrob. Agents Chemother. 59, 3829\u20133837 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6349_CR58","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1128\/AAC.01529-13","volume":"58","author":"LA Ouattara","year":"2014","unstructured":"Ouattara, L. A. et al. MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection. Antimicrob. Agents Chemother. 58, 2841\u20132848 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6349_CR59","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1089\/aid.2012.0073","volume":"28","author":"N Richardson-Harman","year":"2012","unstructured":"Richardson-Harman, N., Mauck, C., McGowan, I. & Anton, P. Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study. AIDS Res. Hum. Retrovir. 28, 1422\u20131433 (2012).","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"6349_CR60","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1128\/JCM.00673-09","volume":"47","author":"N Richardson-Harman","year":"2009","unstructured":"Richardson-Harman, N. et al. Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis. J. Clin. Microbiol. 47, 3530\u20133539 (2009).","journal-title":"J. Clin. Microbiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06349-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T18:11:37Z","timestamp":1671559897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06349-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6349"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06349-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"13 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3881"}}